Clinical trial Recruiting at 1 site Observational Ages 30 to 70

3D bioprinted human spinal unit made from disc cells with gene profiling

Official title: 3D Biomimetic Spine Unit Model Through the Integration of Bioprinting and Transcriptomics (CDP-SUBT)

Run by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio · NCT07250126 · Data updated 2026-11-12

This project will test whether a 3D bioprinted spinal unit made from patients' disc cells reproduces the gene-expression patterns seen in people having surgery for moderate-to-severe degenerative disc disease.

Quick facts

Study typeObservational
Ages30 Years to 70 Years
SexAll
Enrollment5 (estimated)
SponsorI.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Academic / other
Locations1 site (Milan, MI)
StatusRecruiting
StartedNovember 4, 2025
Main results expectedOctober 2027
Study endsOctober 2027
Registry record updatedNovember 26, 2025
Trial IDNCT07250126 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 30–70 with Pfirrmann grade III–V disc degeneration who are scheduled for spinal surgery and can give informed consent, and who do not have the listed blood-borne infections.

Probably not a fit

People who are not undergoing surgery, are outside the 30–70 age range, have milder disc degeneration (Pfirrmann I–II), or have active HIV, HBC, HCV, or TPHA infection are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will collect primary human cells from the nucleus pulposus, annulus fibrosus, and cartilaginous endplate of patients undergoing spinal surgery and define their transcriptional (gene-expression) profiles. Using those data as a reference, they will create a biomimetic spinal unit by bioprinting human cells into a 3D construct that incorporates key disc components. Cells recovered from the bioprinted constructs will undergo the same transcriptomic analyses to compare identity, heterogeneity, and fidelity to native disc tissues. The work is observational and performed at a single clinical site in Milan, with adult surgical patients (age 30–70) and standard infection exclusions.

Why it matters

Potential benefit: If successful, this model could provide a more realistic human-based laboratory platform for testing therapies and understanding disc biology, potentially accelerating development of treatments and reducing reliance on animal models.

How similar studies have gone: Related work has produced disc-like tissues and applied transcriptomics to musculoskeletal models, but fully biomimetic human 3D spinal unit models combining bioprinting and comprehensive transcriptomics remain relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Signature of the Informed Consent for the study
* Age 30-70 years (included)
* Pfirrmann grade III-V
* Need to undergo spinal surgery

Exclusion Criteria:

* Presence of HIV, HBC, HCV or TPHA infection

Where it's running

  • IRCCS Ospedale Galeazzi-Sant'Ambrogio
    Milan, Mi, Italy
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.